75
Participants
Start Date
March 1, 2016
Primary Completion Date
July 1, 2025
Study Completion Date
July 31, 2025
MTL-CEBPA
Intravenous administration
Sorafenib 200mg
Sorafenib tablets
National University Hospital, Singapore
National Taiwan University Hospital, Taipei
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Cambridge University Hospitals NHS Trust, Cambridge
The Beatson West of Scotland Cancer Centre, Glasgow
Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
Guy's and St. Thomas' NHS Foundation Trust, London
Imperial College Healthcare NHS Trust, London
The Royal Free London NHS Foundation Trust, London
University College London Hospitals NHS Foundation Trust, London
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle
Mina Alpha Limited
INDUSTRY